Analysts think ORGO stock price could increase by 93%
Jun 10, 2025, 11:25 AM
29.74%
What does ORGO do
Organogenesis Holdings, a regenerative medical company based in Canton, Massachusetts, specializes in advanced wound care and surgical products, employing 862 staff since its IPO on December 2, 2016. Their portfolio includes Apligraf, Dermagraft, and various placental allografts for treating wounds and soft tissue repairs.
6 analysts think ORGO stock price will increase by 93.29%. The current median analyst target is $6.63 compared to a current stock price of $3.43. The lowest analysts target is $5.05 and the highest analyst target is $7.35.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.